SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HELIX BIOPHARMA (HBP:TSE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trustmanic who wrote (100)9/10/1997 8:53:00 AM
From: burner   of 193
 
Appointment

Helix Biopharma Corp HBP
Shares issued 13,743,415 Sep 9 close $0.66
Wed 10 Sept 97 News Release
Dr Terrance Owen reports
Mr William Chick has been appointed vice-president, sales and marketing of
Rivex Pharmaceuticals, the pharmaceutical division of Helix.
In his new role, Mr Chick will be responsible for overseeing all sales and
marketing functions for Rivex, including the proprietary gastrointestinal
line and the expanding generic product line. His primary mandate will be to
grow the pharmaceutical entity of Helix in Canada.
Mr Chick brings a wealth of experience in both sales and marketing of
pharmaceutical products to Helix. Previously with a major Ontario
pharmaceutical company for 12 years, Bill held positions to increasing
responsibility in the sales and marketing area, most recently holding the
position of director of marketing for that company's therapeutic
businesses.
(c) Copyright 1997 Canjex Publishing Ltd. canada-stockwatch.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News